Lit review
by
Baxley, Catherine et al
Release Date
2022
Geography
International
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
This systematic review investigated buprenorphine doses and formulations on craving during the induction and maintenance phases of treatment, and for context also compared the craving response to other MOUD (i.e., methadone, extended-release naltrexone [XR-NTX]).
Findings/Key points
Craving is reduced over time with buprenorphine and BUP/NAL, although other MOUD may provide greater reductions in craving.
Design/methods
10 studies included
Keywords
Substitution/OAT
